Mcpherson'S Limited (MCP) AI Stock Analysis

• Market Cap: €35.27M
• Dividend Yield: N/A
• Average Volume (3M): 451.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.85
• Revenue Growth: -3.91%
• EPS Growth: 5.94%
• Country: AU
• Employees: 876
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.10
• Shares Outstanding: 143,949,140
• 10 Day Avg. Volume: 1,155,699
• 30 Day Avg. Volume: 451,786
• PEG Ratio: -0.24
• Price to Book (P/B): 0.45
• Price to Sales (P/S): 0.23
• P/FCF Ratio: 20.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: AU$0.50 ▲(100.00% Upside)

Mcpherson's Limited faces significant challenges with profitability and cash flow, which are the most impactful factors on its overall score. Technical indicators show neutral to slightly negative momentum, while valuation metrics highlight concerns with a negative P/E ratio and lack of dividend yield. The absence of earnings call insights and corporate events leaves these areas unaddressed.

Mcpherson'S Limited Business Overview & Revenue Model

Company Description

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. The company was founded in 1860 and is based in Kingsgrove, Australia.

How the Company Makes Money

McPherson's Limited generates revenue through multiple streams, primarily by selling a wide range of health and beauty products to retailers and wholesalers. The company operates on a wholesale distribution model, where it partners with various brands to provide their products to a broad customer base, including major retailers and e-commerce platforms. Key revenue streams include direct sales, private label offerings, and licensing agreements with both domestic and international brands. Additionally, McPherson's Limited benefits from strategic partnerships that enhance its market reach and product offerings, allowing for a steady flow of income through volume sales and brand collaborations.

Mcpherson'S Limited Financial Statement Overview

Summary

Mcpherson's Limited shows mixed financial health with strong revenue growth but persistent profitability issues. The balance sheet reflects improved leverage but negative returns on equity. Cash flow challenges persist, with declining free cash flow and low cash conversion ratios, indicating potential liquidity concerns.

Income Statement

Mcpherson's Limited has experienced fluctuating revenue growth, with a notable 24.14% increase in the latest period, but has consistently faced negative net profit margins, indicating ongoing profitability challenges. The gross profit margin improved significantly to 57.88%, but negative EBIT and EBITDA margins highlight operational inefficiencies.

Balance Sheet

The company's debt-to-equity ratio has improved to 0.10, reflecting better leverage management. However, the return on equity remains negative, indicating challenges in generating returns for shareholders. The equity ratio is stable, suggesting a balanced asset structure.

Cash Flow

Free cash flow has declined significantly by 68.55%, raising concerns about cash generation. The operating cash flow to net income ratio is low, indicating potential issues in converting income into cash. However, the free cash flow to net income ratio is relatively strong, suggesting some efficiency in cash utilization.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	138.99M	138.99M	144.63M	155.23M	214.00M	200.50M
Gross Profit	80.45M	80.45M	35.09M	47.77M	90.80M	87.48M
EBITDA	-6.99M	-6.99M	-4.92M	3.10M	7.44M	5.98M
Net Income	-15.04M	-15.04M	-15.99M	-5.06M	333.00K	-5.37M
Balance Sheet
Total Assets	117.21M	117.21M	146.90M	190.06M	215.76M	199.59M
Cash, Cash Equivalents and Short-Term Investments	9.48M	9.48M	24.77M	7.03M	13.14M	7.35M
Total Debt	7.30M	7.30M	19.85M	25.45M	29.38M	20.93M
Total Liabilities	44.23M	44.23M	57.26M	80.61M	94.95M	84.96M
Stockholders Equity	72.98M	72.98M	89.64M	109.45M	120.81M	114.62M
Cash Flow
Free Cash Flow	1.57M	1.57M	9.64M	4.70M	16.32M	168.00K
Operating Cash Flow	2.21M	2.21M	12.34M	6.55M	18.57M	2.69M
Investing Cash Flow	-3.62M	-3.62M	16.29M	-1.85M	-2.25M	-31.80M
Financing Cash Flow	-13.91M	-13.91M	-10.90M	-10.91M	-10.59M	29.42M

Mcpherson'S Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.25 is below the 20-day moving average (MA) of 0.26, below the 50-day MA of 0.27, and below the 200-day MA of 0.27, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.46 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
S66	―	AU$28.35M	5.40	14.70%	1.76%	6.89%	607.27%
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
ABY	―	AU$100.53M	132.10	1.90%	―	1.58%	-65.09%
MCP	―	€35.27M	-2.34	-20.06%	―	-3.91%	5.94%
PTL	―	€8.18M	-1.77	-22.96%	―	-25.16%	77.62%
CCX	―	AU$31.98M	―	-24.80%	―	2.35%	95.03%
SKN	―	AU$3.15M	―	―	―	12.92%	34.21%

Mcpherson'S Limited Corporate Events

McPherson’s Limited Reports FY25 Revenue and Transformation Progress

McPherson’s Limited has reported expected revenue of $139 million for FY25, with four out of five core brands achieving revenue growth despite challenging conditions. The company has transitioned to a new operating model involving third-party warehousing and pharmacy wholesaler partnerships, which is expected to unlock EBIT benefits of $4 to $5 million annually. This strategic shift is aimed at supporting future growth and enhancing brand investment, positioning McPherson’s for improved operational performance in FY26.